Back to Search
GEORGE MILLS, M.D.
M.D.
Anesthesiology Physician
NPI: 1427147958IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
L4062(TX)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON
Class of 1998
Research & Publications (20)
Linking molecular diagnostics to molecular therapeutics: targeting the PI3K pathway in breast cancer.
PMID 14613030·Semin Oncol·2003
6-review
The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy.
PMID 11706404·Semin Oncol·2001
6-review
Linking molecular therapeutics to molecular diagnostics: inhibition of the FRAP/RAFT/TOR component of the PI3K pathway preferentially blocks PTEN mutant cells in vitro and in vivo.
PMID 11526226·Proc Natl Acad Sci U S A·2001
7-preclinical
Cardio-selective and non-selective beta-blockers in chronic obstructive pulmonary disease: effects on bronchodilator response and exercise.
PMID 19383058·Intern Med J·2010
4-observational
Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase II trial (S0216).
PMID 19557750·Head Neck·2010
3-trial
Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics.
PMID 19435916·Cancer Res·2009
8-other
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer.
PMID 19648920·Nat Genet·2009
8-other
The biology of ovarian cancer: new opportunities for translation.
PMID 19461667·Nat Rev Cancer·2009
6-review
AKT-independent signaling downstream of oncogenic PIK3CA mutations in human cancer.
PMID 19573809·Cancer Cell·2009
8-other
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression.
PMID 19491266·Cancer Res·2009
7-preclinical
Beta-arrestin/Ral signaling regulates lysophosphatidic acid-mediated migration and invasion of human breast tumor cells.
PMID 19609003·Mol Cancer Res·2009
8-other
Expression of autotaxin and lysophosphatidic acid receptors increases mammary tumorigenesis, invasion, and metastases.
PMID 19477432·Cancer Cell·2009
7-preclinical
3-Phosphoinositide-dependent kinase 1 potentiates upstream lesions on the phosphatidylinositol 3-kinase pathway in breast carcinoma.
PMID 19602588·Cancer Res·2009
7-preclinical
Integrative analysis of cyclin protein levels identifies cyclin b1 as a classifier and predictor of outcomes in breast cancer.
PMID 19470724·Clin Cancer Res·2009
8-other
Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors.
PMID 19451593·Clin Cancer Res·2009
7-preclinical
Lysophosphatidic acid-induced transcriptional profile represents serous epithelial ovarian carcinoma and worsened prognosis.
PMID 19440550·PLoS One·2009
8-other
Measurement of numicro and nue events in an off-axis horn-focused neutrino beam.
PMID 19519094·Phys Rev Lett·2009
8-other
Current good manufacturing practices for PET drug products in the United States.
PMID 19652213·J Nucl Med·2009
8-other
Genomic amplicons target vesicle recycling in breast cancer.
PMID 19620778·J Clin Invest·2009
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 405 LONDONDERRY DR, SUITE 105
WACO, TX 76712 - Phone
- (254) 776-0266
Quick Facts
- NPI
- 1427147958
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 28
- Publications
- 20
Are you this provider?
Claim Your Profile